Pure Global
NCT06386952

To Compare People With T2DM Who Have Double Hump Versus Who do Not Have Double Hump

To Compare People With T2DM Who Have Double Dorsal Cervical Fat (Double Hump) Versus Who do Not Have Double Dorsal Cervical Fat (Double Hump)
Diabetes Foundation, India·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Type 2 Diabetes Mellitus With Complication
Study type
Observational
Sponsor & location
Primary sponsor
Diabetes Foundation, India
Location
New Delhi, India
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Jun 30, 2025
Enrollment
200 participants
Primary outcome

Double Hump increases diabetes complications

Summary

Hypothesis: Double Hump in people with T2D is associated with higher magnitude of
 complication than people with single hump or no hump
 
 Objectives: To correlate single and double hump with diabetes complication T2DM patient will
 be recruited from endocrine OPD
 
 1. Clinical History and Examination:
 
 1. General Physical Examination: Height, weight, waist circumference, hip circumference,
 BMI, Blood Pressure, Hand grip. Buffalo Hump.
 
 2. Complications Assessment: Patient will be analyzed for:
 
 Micro Vascular
 
 (a) Diabetic retinopathy (i) Mild NPDR (ii) Mod NPDR (iii) Macular Edema / CSME (b)
 Neuropathy (Mild/Mod/Severe) (c) Chronic Kidney Disease (i) Micro/Macro albumin urea (ii)
 Increased Creatinine (iii) Decreased eGFR
 
 Macro Vascular
 
 1. Low ABI/PAD
 
 2. CVD-MI/PTCA/CABG/Heart Failure
 
 3. CVS-Stroke/ TIA/Carotid Blockage 50%

ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with multiple complicationsType 2 diabetes mellitus without complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06386952
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06386952 through Pure Global AI's free database. This phase not specified trial is sponsored by Diabetes Foundation, India and is currently Recruiting. The study focuses on Type 2 Diabetes Mellitus With Complication. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.